95 related articles for article (PubMed ID: 388799)
21. Bone marrow acid phosphatase in prostate cancer: an assessment by immunoassay and biochemical methods.
Romas NA; Veenema RJ; Hsu KC; Tomashefsky P; Lattimer JK; Tannenbaum M
Trans Am Assoc Genitourin Surg; 1979; 71():26-30. PubMed ID: 545810
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of two serum isoenzyme phosphatases as bone metastasis markers].
Desoize B; Pourny C; Amico S; Larbre H; Jardillier JC
Bull Cancer; 1990; 77(12):1211-21. PubMed ID: 2081281
[TBL] [Abstract][Full Text] [Related]
23. [Cancer of the prostate: the markers other than prostatic acid phosphatase].
Soula G
Bull Cancer; 1985; 72(6):527-30. PubMed ID: 2418900
[TBL] [Abstract][Full Text] [Related]
24. [Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein].
Yoshiki T; Okada K; Oishi K; Yoshida O
Hinyokika Kiyo; 1987 Dec; 33(12):2044-9. PubMed ID: 2452559
[TBL] [Abstract][Full Text] [Related]
25. Prostatic acid phosphatase: clinical utility in detection, assessment, and monitoring carcinoma of the prostate.
Pappas AA; Gadsden RH
Ann Clin Lab Sci; 1984; 14(4):285-91. PubMed ID: 6465831
[TBL] [Abstract][Full Text] [Related]
26. Enzyme patterns in cancer.
Schwartz MK
Ann Clin Lab Sci; 1977; 7(2):99-104. PubMed ID: 322572
[TBL] [Abstract][Full Text] [Related]
27. [Clinical study of tumor markers in prostatic carcinoma--an investigation on the simultaneous measurement of prostatic acid phosphatase (PAP), prostatic antigen (PA) and gamma-seminoprotein (gamma-Sm)].
Tsukamoto T; Kumamoto Y; Yamazaki K; Umehara T; Miyao N; Ohmura K; Iwazawa M
Hinyokika Kiyo; 1988 Jun; 34(6):987-95. PubMed ID: 2464917
[TBL] [Abstract][Full Text] [Related]
28. Biological markers in prostate cancer.
Pontes JE
J Urol; 1983 Dec; 130(6):1037-47. PubMed ID: 6196490
[No Abstract] [Full Text] [Related]
29. [Serum acid phosphatase determined by the radioimmunochemical method (P.A.P.-RIA): its diagnostic value in prostatic cancer].
Marczyńska A; Kulpa J; Adamczyk B; Leńko J
Przegl Lek; 1982 Sep; 39(8):573-6. PubMed ID: 6182582
[No Abstract] [Full Text] [Related]
30. EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancer.
Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Yen CC; Chen WS; Jiang JK; Yang SH; Wang HS; Chen PM
Hepatogastroenterology; 2004; 51(55):136-41. PubMed ID: 15011849
[TBL] [Abstract][Full Text] [Related]
31. [Significance of prostate fluid carcinoembryonic antigen in the diagnosis of prostate cancer].
Hayashi T; Yamauchi A; Hosoda K
Hinyokika Kiyo; 1995 Jul; 41(7):525-8. PubMed ID: 7545350
[TBL] [Abstract][Full Text] [Related]
32. Acid phosphatase, alkaline phosphatase and prostate-specific antigen--usefulness in the diagnosis of metastatic disease and follow-up.
Bauer HW
Prog Clin Biol Res; 1988; 269():33-42. PubMed ID: 2455908
[TBL] [Abstract][Full Text] [Related]
33. Prostatic acid phosphatase in serum and bone marrow in patients with prostatic carcinoma.
Fossà SD; Skinningsrud A; Kaalhus O; Engeset A
Br J Urol; 1983 Jun; 55(3):306-11. PubMed ID: 6850249
[TBL] [Abstract][Full Text] [Related]
34. Immunologic markers and the diagnosis of prostatic cancer.
Ban Y; Wang MC; Chu TM
Urol Clin North Am; 1984 May; 11(2):269-76. PubMed ID: 6203206
[TBL] [Abstract][Full Text] [Related]
35. Carcinoembryonic antigen and human chorionic gonadotrophin in breast carcinoma and prostatic specific acid phosphatase in prostate carcinoma.
Arora B; Chhabra A; Yadav MS; Arora DR
Indian J Pathol Microbiol; 1990 Jul; 33(3):235-8. PubMed ID: 1965432
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow acid phosphatase by radioimmunoassay.
Belville WD; Cox HD; Mahan DE; Olmert JP; Mittemeyer BT; Bruce AW
Cancer; 1978 Jun; 41(6):2286-91. PubMed ID: 77719
[TBL] [Abstract][Full Text] [Related]
37. Tumor antigen and acid phosphatase isoenzyme in prostatic cancer.
Chu TM; Bhargava A; Barnard EA; Ostrowski W; Varkarakis MJ; Merrin C; Murphy GP
Cancer Chemother Rep; 1975; 59(1):97-103. PubMed ID: 48419
[TBL] [Abstract][Full Text] [Related]
38. Reliability of bone marrow acid phosphatase as a parameter of metastatic prostatic cancer.
Pontes JE; Choe B; Rose N; Pierce JM
J Urol; 1979 Aug; 122(2):178-9. PubMed ID: 459010
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of serum and bone marrow acid phosphatase.
Pontes JE
Prostate; 1980; 1(4):465-70. PubMed ID: 7024959
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow acid phosphatase by radioimmunoassay: 3 years of experience.
Belville WD; Mahan DE; Sepulveda RA; Bruce AW; Miller CF
J Urol; 1981 Jun; 125(6):809-11. PubMed ID: 7241679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
